Habitrol and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Habitrol (nicotine) and Levaquin (levofloxacin). Common drug interactions include scoliosis among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Habitrol and Levaquin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Habitrol?

Habitrol has active ingredients of nicotine. eHealthMe is studying from 5,553 Habitrol users. Check the latest studies of Habitrol.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.



On Jul, 25, 2026

19 people who take Habitrol and Levaquin together, and have interactions are studied.

Habitrol and Levaquin drug interactions.

What are the common drug interactions of Habitrol and Levaquin, by gender? *:

female:

  1. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  2. Sputum purulent
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Vertebral foraminal stenosis (narrowing of the intervertebral foramen)
  5. Bone pain
  6. Insomnia (sleeplessness)
  7. Protein total increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Dizziness
  10. Intervertebral disc compression (spinal disc compression)

male:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Abdominal pain
  3. Nausea (feeling of having an urge to vomit)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Renal failure chronic (long lasting kidney dysfunction)
  6. Vomiting
  7. Blood gases
  8. Fungal test positive
  9. Sunburn
  10. Weight increased

What are the common drug interactions of Habitrol and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. Abdominal pain
  3. Arthralgia (joint pain)
  4. Asthma
  5. Back pain
  6. Bradycardia (abnormally slow heart action)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Chest discomfort
  9. Chest pain
  10. Cholecystitis (infection of gallbladder)

40-49:

n/a

50-59:

  1. Bone pain
  2. Insomnia (sleeplessness)
  3. Protein total increased
  4. Intervertebral disc compression (spinal disc compression)
  5. Monocyte count decreased
  6. Pleurodesis
  7. Spinal cord compression
  8. Alanine aminotransferase decreased
  9. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
  10. Alopecia (absence of hair from areas of the body)

60+:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Nausea (feeling of having an urge to vomit)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Renal failure chronic (long lasting kidney dysfunction)
  6. Vomiting
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cardiac failure
  9. Joint swelling
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 5 people, 26.32%
  2. Bone Cancer Metastatic: 5 people, 26.32%
  3. Breast Cancer: 5 people, 26.32%
  4. Osteomyelitis (infection of bone): 4 people, 21.05%
  5. Stress And Anxiety: 4 people, 21.05%
  6. Quit Smoking: 4 people, 21.05%
  7. Urinary Tract Infection: 3 people, 15.79%
  8. Insomnia (sleeplessness): 3 people, 15.79%
  9. Blood Pressure Systolic Increased: 2 people, 10.53%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Habitrol and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Habitrol and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Habitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Habitrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on nicotine and levofloxacin (the active ingredients of Habitrol and Levaquin, respectively), and Habitrol and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: